HB2382 Summary

• Permits pharmaceutical manufacturers and representatives to engage in truthful promotion of off-label drug, biological product, and device uses without legal restriction.

• Prohibits state officials and regulatory boards from enforcing misbranding laws or prosecuting pharmaceutical manufacturers for truthful off-label promotion.

• Prevents the Arizona State Board of Pharmacy, Medical Board, Board of Osteopathic Examiners, and Department of Health Services from revoking or denying license renewal based on truthful off-label promotion.

• Does not require health insurers or third-party payors to cover costs of off-label treatments.

• Defines "truthful promotion" as non-misleading information consistent with scientific principles shared between manufacturers and licensed prescribers.